Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Checkpoint Therapeutics Inc (CKPT)
NASDAQ:CKPT
RESEARCH TOOLSreports
Checkpoint Therapeutics (CKPT) Stock Price & Analysis
1,556 Followers
CKPT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.30 - $10.20
Previous Close$1.94
Volume427.96K
Average Volume (3M)288.67K
Market Cap
$40.53M
Enterprise Value$33.11M
Total Cash (Recent Filing)$7.42M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-0.4
Beta1.37
Next Earnings
Nov 08, 2023EPS Estimate
-$0.74Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.18
Shares Outstanding21,593,485
10 Day Avg. Volume260,910
30 Day Avg. Volume288,672
Standard Deviation0.24
R-Squared0.10
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)-2.20
Price to Sales (P/S)1307.53
Price to Cash Flow (P/CF)-0.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue176.13
Enterprise Value/Gross Profit172.46
Enterprise Value/Ebitda-0.61
Forecast
1Y Price Target
$24.80Price Target Upside1146.23% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Checkpoint Therapeutics News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CKPT FAQ
What was Checkpoint Therapeutics Inc’s price range in the past 12 months?
Checkpoint Therapeutics Inc lowest stock price was $1.30 and its highest was $10.20 in the past 12 months.
What is Checkpoint Therapeutics Inc’s market cap?
Currently, no data Available
When is Checkpoint Therapeutics Inc’s upcoming earnings report date?
Checkpoint Therapeutics Inc’s upcoming earnings report date is Nov 08, 2023 which is in 20 days.
How were Checkpoint Therapeutics Inc’s earnings last quarter?
Checkpoint Therapeutics Inc released its earnings results on Aug 14, 2023. The company reported -$1.05 earnings per share for the quarter, missing the consensus estimate of -$0.768 by -$0.282.
Is Checkpoint Therapeutics Inc overvalued?
According to Wall Street analysts Checkpoint Therapeutics Inc’s price is currently Undervalued.
Does Checkpoint Therapeutics Inc pay dividends?
Checkpoint Therapeutics Inc does not currently pay dividends.
What is Checkpoint Therapeutics Inc’s EPS estimate?
Checkpoint Therapeutics Inc’s EPS estimate is -$0.74.
How many shares outstanding does Checkpoint Therapeutics Inc have?
Checkpoint Therapeutics Inc has 20,893,484 shares outstanding.
What happened to Checkpoint Therapeutics Inc’s price movement after its last earnings report?
Checkpoint Therapeutics Inc reported an EPS of -$1.05 in its last earnings report, missing expectations of -$0.768. Following the earnings report the stock price went down -3.349%.
Which hedge fund is a major shareholder of Checkpoint Therapeutics Inc?
Among the largest hedge funds holding Checkpoint Therapeutics Inc’s share is Fisher Asset Management LLC. It holds Checkpoint Therapeutics Inc’s shares valued at N/A.
---
Checkpoint Therapeutics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$24.80 (1146.23% Upside)
$24.80 (1146.23% Upside)
Blogger Sentiment
Bullish
CKPT Sentiment 100%
Sector Average 68%
Sector Average 68%
Crowd Wisdom
Very Negative
Last 7 Days ▲ 0.4%
Last 30 Days ▼ 4.9%
Last 30 Days ▼ 4.9%
News Sentiment
Positive
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-80.23%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-74.01%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Checkpoint Therapeutics Inc
Checkpoint Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. Its product portfolio include CK-301, CK-101, CK-103, and CK-302. The company was founded on November 10, 2014 and is headquartered in New York, NY.
---
Top 5 ETFs holding CKPT
Vanguard Total Stock Market ETF
$499.02K
Up to five ETFs with an Outperform Smart Score that hold CKPT. The ETFs are listed according to market value of CKPT within the ETF
---